Best Magnesium for Sleep: Ranked by RCT Evidence (2026)

Of the five commercially available magnesium forms marketed for sleep, one has a dedicated independent randomized controlled trial, two have high bioavailability verified in human crossover trials, one has brain-preferential claims derived from rat data, and one is the cheapest and worst-performing option that somehow still dominates supplement shelves. This ranking is built from RCT evidence, bioavailability trials, and mechanistic plausibility — not sponsored claims or marketing copy.

Scoring rubric

Each form is scored on four criteria (0–10 each, averaged):

1. RCT evidence quality: Are there independent, placebo-controlled human trials with sleep as the primary endpoint? What are the sample sizes and effect sizes?
2. Bioavailability: Does human data confirm adequate intestinal absorption at sleep-relevant doses?
3. Safety profile: GI tolerance, drug interactions, contraindications at standard doses.
4. Mechanistic plausibility: Is there a documented biological pathway connecting the specific form to sleep improvement, beyond generic magnesium repletion?

Magnesium forms for sleep — evidence scoring rubric

#1 Magnesium glycinate (bisglycinate) — Score: 9.1

The only form with a dedicated independent 2025 sleep RCT.

Schuster et al. (2025) randomized 155 healthy adults with self-reported poor sleep quality to 250 mg elemental magnesium as bisglycinate versus placebo for 8 weeks. ISI (Insomnia Severity Index) scores improved significantly from Week 4, with Cohen's d = 0.2 at endpoint.

Cohen's d = 0.2 is small. In the context of a non-prescription supplement in a non-clinically-insomniac population compared to placebo, it is a real signal that survived an 8-week blinded trial. The 2021 Mah and Pitre meta-analysis (3 RCTs, 151 older adults) found sleep onset latency fell 17 minutes post-magnesium supplementation versus placebo — consistent with the Schuster magnitude.

Mechanism: Glycinate carries a dual payload. Magnesium potentiates GABA-A receptors, reducing neuronal excitability. Glycine itself is an inhibitory neurotransmitter — a co-agonist at NMDA receptors in the brainstem and spinal cord. Bannai et al. (2012) showed oral glycine at 3g improved subjective sleep quality and reduced sleep onset latency in a small placebo-controlled trial; the glycinate chelate delivers both compounds simultaneously, though at lower glycine doses than the Bannai trial.

Bioavailability: Absorbed via dedicated PEPT1 and SLC amino acid transport pathways. Walker et al. (2003) showed citrate outperforms oxide in a human crossover; glycinate's absorption via amino acid transport is mechanistically distinct and similarly efficient.

Safety: Well-tolerated at doses up to 400 mg elemental in trials. Minimal GI effects. The same drug interactions that apply to all oral magnesium forms apply here: proton pump inhibitors (omeprazole, pantoprazole, esomeprazole) impair TRPM6/TRPM7 transport, reducing absorption. Kidney disease is a contraindication — magnesium accumulates with impaired renal clearance.

Protocol: 200–400 mg elemental magnesium as bisglycinate, 45–60 minutes before bed. Effect may take 4–8 weeks to manifest at consistent dosing.

#2 Magnesium citrate — Score: 7.4

Best-evidenced high-bioavailability form without a dedicated sleep trial.

Magnesium citrate is an organic salt with superior bioavailability over oxide, confirmed in a human randomized crossover trial. Walker et al. (2003) used urinary magnesium excretion as an absorption proxy — citrate significantly outperformed oxide.

What keeps it at #2: No dedicated sleep RCT. The sleep benefit for all forms is attributable to magnesium repletion in deficient populations — the Mah and Pitre (2021) meta-analysis, which includes mixed-form trials, found 17 minutes of sleep onset improvement. But the glycinate trial (Schuster 2025) is the only one that specifically attributes that signal to a form with independent investigation. Citrate has not had that trial run.

Abbasi et al. (2012) — the most-cited magnesium sleep trial — used oxide (500 mg elemental daily in 46 elderly subjects), not citrate. The positive sleep findings in that trial (sleep efficiency 0.63 → 0.73) are complicated by the low bioavailability of oxide. Citrate, with better absorption, might outperform oxide in a direct comparison — but no trial has run this.

Practical consideration: Laxative effect begins at approximately 300 mg elemental. For the full 400 mg sleep dose, glycinate avoids this; citrate at that dose produces GI effects in a significant subset of users.

Safety: Same contraindications as glycinate. GI tolerability is the key practical differentiator.

Protocol: 150–200 mg elemental, 45–60 minutes before bed, to stay below the laxative threshold.

#3 Magnesium L-threonate (Magtein) — Score: 6.2

One promising but industry-funded RCT. Brain-crossing claims based on rat data.

The threonate form arrived with a specific claim: preferential brain magnesium elevation. Slutsky et al. (2010) in Neuron showed MgT raised brain magnesium and improved memory in rats.

That paper is rodent data. The marketing uses it as human claims.

The first human sleep RCT: Rountree et al. (2024), 80 adults, 1 g MgT daily (75 mg elemental magnesium) for 21 days. ISI scores dropped from 12.46 to 7.86 in the MgT group versus 12.57 to 9.39 in placebo (p = 0.0001).

The numbers look strong. The conflict of interest disclosure undermines them: funded by AIDP Inc., authors affiliated with AIDP, Magtein supplied by Threotech (the patent holder). A 2025 independent trial in Frontiers in Nutrition (Arab et al.) tested Magtein in a double-blind RCT and found weaker objective sleep signals — the difference between industry-sponsored and independent results is a known pattern in supplement research.

Score penalty: The "brain-preferential" mechanism in humans has not been independently confirmed. Elemental magnesium per dose is low (75 mg from 1 g MgT) compared to glycinate's 200–400 mg. If the benefit is primarily from magnesium repletion, the low elemental dose makes it a suboptimal delivery vehicle. Cost is significantly higher than glycinate or citrate: $40–$80 per month versus $15–$30 for glycinate.

#4 Magnesium oxide — Score: 3.8

Worst absorption, most common in old trials, still dominates cheap supplements.

Magnesium oxide has approximately 4% bioavailability in some estimates — the rest transits the colon, acting as an osmotic laxative. The Abbasi et al. (2012) sleep trial used oxide at 500 mg elemental — positive results, but the absorption problem means most of that dose didn't reach systemic circulation.

The trial is positive despite using the worst-absorbed form. The explanation is likely twofold: participants were elderly (a population with higher deficiency prevalence) and used very high elemental doses (500 mg) — even at 4% absorption, 500 mg elemental delivers 20 mg absorbed. Additionally, the osmotic laxative effect itself may indirectly benefit sleep in constipated elderly patients, a confound not controlled for.

Why it still sells: Highest elemental magnesium per milligram of compound, cheapest to manufacture. The label "500 mg magnesium" refers to elemental content, not absorbed dose. Supplement manufacturers are not required to disclose bioavailability.

Recommendation: Do not use oxide as a first-choice form for sleep. If a multi-ingredient product contains oxide as the magnesium source, consider the effective magnesium dose as approximately 4% of the labeled elemental content.

What to buy

For sleep as the primary goal: magnesium glycinate (bisglycinate), 200–400 mg elemental, 45–60 minutes before bed. Generic versions work; "Albion chelate" branding does not have independently stronger RCT evidence than non-branded bisglycinate.

For general magnesium repletion at lower cost: magnesium citrate, 150–200 mg elemental. Verify the dose per serving is in the repletion range and not the laxative range (which requires 1–2 g elemental).

Avoid as primary sleep supplements: oxide (poor absorption), taurate (no sleep trials), malate (no sleep trials).

Who the evidence applies to: approximately 48% of U.S. adults consume below the magnesium EAR from diet alone. The sleep benefits described in trials — 17 minutes faster sleep onset, Cohen's d = 0.2 on ISI — are population effects in deficient populations. If dietary magnesium is adequate, supplementation is unlikely to move sleep metrics.

The magnesium-for-sleep benefit is real, replicable, and modest. The form matters more than the marketing admits.

Related transmissions

Magnesium for Sleep: What 60+ Studies Show — full deep-dive covering all six forms, the 2025 Schuster bisglycinate RCT, dose-response data, and drug interactions.

Magnesium Glycinate vs Citrate: Which Is Better? — direct form comparison with side-by-side properties table.

FAQ

Which magnesium is best for sleep according to research?

Magnesium glycinate (bisglycinate) is the best-evidenced form for sleep as of 2026, based on the 2025 Schuster RCT (n=155, Cohen's d = 0.2 at 250 mg elemental). It also has a dual mechanism (magnesium + glycine GABA-A potentiation) and minimal GI side effects at therapeutic doses.

Is magnesium glycinate or threonate better for sleep?

Glycinate has stronger independent evidence. The 2025 Schuster bisglycinate trial is independent and well-powered. The threonate trials — particularly the 2024 Rountree RCT — were industry-funded. The independent 2025 Arab et al. Frontiers in Nutrition trial found weaker objective sleep signals for threonate.

How much magnesium should I take for sleep?

Trials showing sleep effects used 200–400 mg elemental magnesium daily. The Schuster 2025 bisglycinate trial used 250 mg elemental. The Mah and Pitre (2021) meta-analysis suggests a ceiling below 1 gram daily. Start at 200 mg elemental and reassess after 4–8 weeks.

Does magnesium help with sleep if I'm not deficient?

The evidence is weaker. The strongest effects appear in populations running below the magnesium EAR (approximately 48% of US adults). If dietary magnesium is adequate, supplementation is unlikely to produce measurable sleep improvement based on current trial data.

Sources

1. Schuster J, et al. (2025). Magnesium Bisglycinate Supplementation in Healthy Adults Reporting Poor Sleep. Nature and Science of Sleep. PMC12412596.
2. Mah J, Pitre T. (2021). Oral magnesium supplementation for insomnia in older adults. BMC Complementary Medicine and Therapies. PMC8053283.
3. Walker AF, Marakis G, Christie S, Byng M. (2003). Mg citrate found more bioavailable than other Mg preparations. Magnesium Research. PubMed 14596323.
4. Bannai M, Kawai N, Ono K, et al. (2012). New therapeutic strategy for amino acid medicine: glycine improves the quality of sleep. Sleep and Biological Rhythms. PubMed 25237036.
5. Rountree R, et al. (2024). Magnesium-L-threonate improves sleep quality in adults. Sleep Medicine: X. PMC11381753.
6. Slutsky I, Abumaria N, Wu LJ, et al. (2010). Enhancement of Learning and Memory by Elevating Brain Magnesium. Neuron, 65(2). PubMed 20152124.
7. Abbasi B, Kimiagar M, Sadeghniiat K, et al. (2012). The effect of magnesium supplementation on primary insomnia in elderly. Journal of Research in Medical Sciences. PMC3703169.
8. Boyle NB, Lawton C, Dye L. (2017). The Effects of Magnesium Supplementation on Subjective Anxiety and Stress. Nutrients, 9(5). PMC5452159.
9. Arab A, et al. (2025). The effects of magnesium L-threonate (Magtein®) on cognitive performance and sleep quality. Frontiers in Nutrition.
10. Gommers LM, Hoenderop JG, de Baaij JH. (2022). Mechanisms of proton pump inhibitor-induced hypomagnesemia. Acta Physiologica. PMC9539870.
11. NIH Office of Dietary Supplements. (2022). Magnesium — Health Professional Fact Sheet. ods.od.nih.gov.
12. Held K, Antonijevic IA, Künzel H, et al. (2002). Oral Mg(2+) supplementation reverses age-related neuroendocrine and sleep EEG changes. Pharmacopsychiatry, 35(4). PubMed 12163983.